Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
SynGen history
SynGen company history timeline
The state-of-the-art Research and Development center will focus on the development of science-based affordable nutrition products for the country and enable the expansion of Abbott's nutrition product portfolio.In 2012 Syngene International received ANVISA Certification of clinical facilities.
Syngene and Baxter originally established the Baxter Global Research Center a dedicated R&D center in 2013.
The strategic partnership will help Herbalife Nutrition develop and formulate world-class nutrition products for Indian consumers.On 27 July 2017 Syngene International announced the expansion of its research collaboration with Amgen Inc.
Shaw is the only Indian in the Hurun Global Self-Made Women Billionaires List 2017.
She is ranked #1 in the Business Captains category in Global ‘Medicine Maker Power List’ 2018.
Prior to joining Foghorn Therapeutics in 2018, he served as the Head of Discovery at Bristol-Myers Squibb (BMS) and was responsible for the discovery and advancement of drug candidates for clinical studies.
She retired as audit partner from Price Waterhouse in June 2019.
Syngenta raises the sales target for its eight key crops to $25 billion by 2020, reflecting the accelerating rate of innovation and strategy delivery.
At 1.79 million, demat accounts opened in June fewest since Feb 2021
Rate SynGen's efforts to communicate its history to employees.
SynGen jobs
Do you work at SynGen?
Is SynGen's vision a big part of strategic planning?
SynGen history FAQs
Zippia gives an in-depth look into the details of SynGen, including salaries, political affiliations, employee data, and more, in order to inform job seekers about SynGen. The employee data is based on information from people who have self-reported their past or current employments at SynGen. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by SynGen. The data presented on this page does not represent the view of SynGen and its employees or that of Zippia.
SynGen may also be known as or be related to SynGen, SynGen Inc and SynGen Inc.